Posts

Showing posts with the label Graves’ Disease

Graves’ Disease – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026

Graves’ Disease Emerging Therapy and TPP Insights Thelansis’s “Graves’ Disease Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Graves’ Disease Overview Graves’ disease is an autoimmune disorder in which thyroid‑stimulating immunoglobulins activate the TSH receptor, causing hyperthyroidism with symptoms such as weight loss, heat intolerance, palpitations, tremor, and goiter; it commonly produces thyroid eye disease (orbitopathy) and occasionally pretibial myxedema. Untreated hyperthyroidism can cause cardiac complications, bone loss, menstrual and fertility disturbances, and risks during pregnancy for both mother and fetus. Graves’ disease often coexists with other autoimmune conditions (for example, type 1 diabetes, perni...

Graves’ Disease – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026

Graves’ Disease Emerging Therapy and TPP Insights Thelansis’s “Graves’ Disease Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Key business questions answered: Detailed emerging competitive landscape Pipeline analysis Target patients for emerging therapies Key companies Key mechanism of actions Launch date estimates, etc. Clinical trial landscape analysis Target patient segments Trial endpoints Trial design Recruitment criteria, etc. Unmet Needs and Opportunities Performance of key current therapies Top areas of unmet needs Opportunity sizing for key unmet needs Target Product Profiles Attributes an...

Graves’ Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Graves’ Disease Market Outlook Thelansis’s “Graves’ Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Graves’ Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What insights do...

Graves’ Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Graves’ Disease Market Outlook Thelansis’s “Graves’ Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Graves’ Disease   treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Graves’ Disease Overview Graves’ Disease, an autoimmune disorder, leads to hyperthyroidism, an excessive production of thyroid hormones. The condition arises when the body’s immune system mistakenly attacks the thyroid gland, prompting it to generate more thyroid hormone than necessary. Situated in the neck, the thyroid, resembling a small butterfly, regulates energy usage throughout the body, influencing the function of almost every organ, including heart...

Graves’ Disease – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030

Image
  Graves' Disease is an autoimmune disorder that results in hyperthyroidism or an overactive thyroid. With this disease, the immune system attacks the thyroid and causes it to make more thyroid hormone than the body needs. The thyroid is a small, butterfly-shaped gland in the neck. Thyroid hormones control how the body uses energy, so they affect nearly every organ in your body, even the way your heartbeats. If left untreated, hyperthyroidism can cause serious heart, bones, muscles, menstrual cycle, and fertility problems. Untreated hyperthyroidism can cause complications for the mother and the baby during pregnancy. Graves' Disease can also have an impact on the eyes and skin. People who have other autoimmune disorders are more likely to develop Graves' Disease than those who do not. Rheumatoid arthritis, a condition that affects the joints and sometimes other body systems; pernicious anemia, an infection caused by a vitamin B12 deficiency; lupus, a chronic or long-term a ...